RMT

Insider Trades

Actor	Holding Value	Last Transaction	Amount	Transaction Price	Current Price
Denneen John EOfficer, Other: Secretary --4k shares BuyJun 5, 2026 $54.8K4k shares $13.70 --

News

gurufocus.comRoyce Micro-Cap Trust, Inc. (NYSE-RMT) declares Second Quarter Common Stock Distribution of $0.21 Per Sharegurufocus.comJun 1

prnewswire.comRoyce Micro-Cap Trust, Inc. (NYSE-RMT) declares Second Quarter Common Stock Distribution of $0.21 Per Shareprnewswire.comJun 1

gurufocus.comRoyce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026gurufocus.comMay 20

prnewswire.comRoyce Micro-Cap Trust (NYSE: RMT) as of Apr 30, 2026prnewswire.comMay 20

globenewswire.comResolution Therapeutics to showcase key preclinical data on its Regenerative Macrophage Therapy (RMT) RTX001 in oral presentation at ASGCT 2026globenewswire.comMay 12

Trade RMT

About Royce Micro-Cap Trust, Inc.

The Royce Micro-Cap Trust, Inc. functions as a closed-end equity mutual fund, which was both created and is actively managed by Royce & Associates, LLC. This investment vehicle concentrates its holdings within the publicly traded companies of the United States. Its primary objective is to seek out value stocks from a diverse range of sectors, specifically targeting businesses with a market capitalization below $500 million. To gauge its performance, the fund benchmarks itself against the Russell 2000 Index. Established in the United States, Royce Micro-Cap Trust, Inc. began its operations on December 14, 1993.

CEO: Charles Morgan Royce
IPO Date: Dec 15, 1993

Market Data

Open: $13.83
High: $14.02
Low: $13.35
Volume: 167.8K
52W High: $14.30
52W Low: $8.66

Valuation

Market Cap: $733M
Enterprise Value: $753M

Financials

Free Cash Flow: $-2.9M
Revenue: $44M
Net Income: $88M
Cash: $39k
Debt: $20M

Events

DividendJun 11

$0.21